15 Biggest Neuroscience Companies in the World
As the name suggests, neuroscience concerns itself with the development, structure, and functions of the nervous system, intending to enhance neurological health.
Neurocrine Biosciences Inc (NBIX)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
10 Best Healthcare Stocks For Recession
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
5 Best Pharmaceutical Stocks to Buy According to Steven Boyd's Armistice Capital
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
Harding Loevner's Biggest Contributor: Neurocrine Biosciences (NBIX)
Harding Loevner, an asset management company, released its “Global Small Companies Equity” second quarter investor letter. A copy of the same can be downloaded here.
Is it a Great Move to Buy Neurocrine Biosciences (NBIX) Shares?
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” first quarter 2022 investor letter – a copy of which can be downloaded here.
Were Hedge Funds Right About Neurocrine Biosciences, Inc. (NBIX)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
5 Biotech Stocks to Buy According to Matthew Strobeck's Birchview Capital
In this article, we discuss 5 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Neurocrine Biosciences, Inc. (NBIX) Fell Out Of Favor With Hedge Funds
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
15 Best Stocks to Buy for 2022 According to Analysts
In this article, we discuss the 15 best stocks to buy for 2022 according to analysts.
Hedge Funds Are Coming Back To Neurocrine Biosciences, Inc. (NBIX)
Is Neurocrine Biosciences, Inc.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
